Aspects of the thromboxane receptor system
- 31 May 1995
- journal article
- review article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 26 (3) , 463-472
- https://doi.org/10.1016/0306-3623(94)00183-n
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Cloning and Expression of the EP2 Subtype of Human Receptors for Prostaglandin E2Biochemical and Biophysical Research Communications, 1993
- Reduction in the number of thromboxane receptors on human platelets after exposure to GR32191British Journal of Pharmacology, 1993
- Characteristics of the binding of [3H]‐GR32191 to the thromboxane (TP‐) receptor of human plateletsBritish Journal of Pharmacology, 1993
- Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptorsBritish Journal of Pharmacology, 1989
- Effect of a thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstrictionJournal of Applied Physiology, 1989
- Inositol 1,4,5‐trisphosphate (IB3) induced rapid formation of thromboxane B2 in saponin‐permeabilised human platelets: mechanism of IP3 actionFEBS Letters, 1987
- Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimeticsBritish Journal of Pharmacology, 1986
- Synthesis of thromboxane A2Journal of the American Chemical Society, 1985
- Competitive antagonism at thromboxane receptors in human plateletsBritish Journal of Pharmacology, 1985
- Ligand binding to thromboxane receptors on human platelets: correlation with biological activityBritish Journal of Pharmacology, 1983